AzTrials
AzTrials

Knee OsteoarthritisUKA or TKA?NCT02563756

Unicondylar- or Total Knee Replacement? Patient Satisfaction, Function and Muscle Mass

A study testing Unicompartmental knee replacement and Total knee replacement in people with Knee Osteoarthritis, run by Karolinska Institutet at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients with medial gonarthritis are randomised to a unicompartmental or a total knee replacement. Primary outcome: Thigh muscle cross sectional area and radiological attenuation measured by CT Secondary aims: functional tests, gait analysis, health related quality of life and patient related outcome. Read more about this study

Who is it for?
Ages 50 to 100 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
Unicompartmental knee replacement and Total knee replacement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteSweden
Study dates
Sep 2015to Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • medial gonarthritis, (Kellgren 3b-4)
  • correctible varus deformity less than 10 degrees
  • intact ACL
  • proficient in written and spoken swedish

Who cannot join

  • Valgus gonarthritis
  • flexion deformity of 10 degrees
  • knee flexion of less than 100 degrees
  • previous high tibial osteotomy
  • neuromuscular disorders of lower extremities
  • symptomatic osteoarthritis of the contralateral knee or any hip.

Trial locations and contacts

1 site in 1 country.

Margareta Hedström, MD, PhD contact

+4670735959

margareta.hedstrom@ki.se

Nicolas Martinez, MD contact

+46709900089

Sweden1 site, 1 recruiting
  • Karolinska University Hospital

    Stockholm

    Carl Aulin, MD, carl.aulin@karolinska.se

    Nicolas Martinez, MD, +46709900089, nicolas.martinez-carranza@karolinska.se

    Recruiting

Other trials in Sweden

About this study

Official title: Unicondylar - or Total Knee Replacement in Medial Gonarthritis? A Randomized Study of Patient Related Outcome Measures, Function and Muscle Mass

Patients with medial gonarthritis are randomised to a unicompartmental or a total knee replacement.

Primary outcome: Thigh muscle cross sectional area and radiological attenuation measured by CT Secondary aims: functional tests, gait analysis, health related quality of life and patient related outcome.

Read the detailed description

Objective: The investigators aim with the present study was to compare patient related outcome measurements, knee function and muscle mass in patients operated with an UKR or a TKR for medial gonarthritis.

Hypothesis: The investigators hypothesize that a greater number of patients might benefit from a less invasive surgery in terms of increased quality of life, function and muscle mass.

Primary Outcome: Thigh muscle cross sectional area and radiological attenuation measured by CT.

Secondary outcomes: Functional tests (timed up and go, 30s sit and stand, forward reach, forward step down, 6 min walk and 40 m walk test), knee strength (Biodex isokinetic dynamometer) and patient reported pain on a visual analogue scale (VAS). A number of PROMs: Health related quality of life (EQ-5D), Knee injury and Osteoarthritis Outcome Score (KOOS), Oxford Knee Score (OKS) and Forgotten Joint Score (FJS) as well as 3D movement and gait analysis.

Inclusion criteria: Unilateral medial osteoarthritis of the knee (Kellgren 3b-4), aged 50 or above.

Exclusion criteria: Insufficient anterior cruciate ligament (ACL). Fixed varus deformity >10°, fixed flexion deformity >10°, flexion <100°. Previous high tibial osteotomy on the same side. Any neurological disease affecting strength or locomotion in any leg. Body mass index (BMI) >35. Rheumatoid disease. Symptomatic osteoarthritis of the contra lateral knee or any hip. Insufficient written or spoken Swedish.

Being tested
Unicompartmental knee replacement, Total knee replacement
Keywords
Medial gonarthritis, knee osteoarthritis,, Muscle function, muscle mass, muscle atrophy, Total knee arthroplasty (TKA), Unicondylar knee arthroplasty (UKA), Total knee replacement (TKR), Unicondylar knee replacement (UKR), Health-related quality of life (HRQoL), Patient related outcome measurements (PROMs)
Medical subject headings
Osteoarthritis, Knee, Muscular Atrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Unicompartmental knee replacementProcedure or surgery

    Also called Oxford

    Participants with a medial gonarthritis are operated with a medial unicompartmental prosthesis

  • Total knee replacementProcedure or surgery

    Also called PFC

    Participants with a medial gonarthritis are operated with a total knee replacement

Study groups in NCT02563756
Study groupRoleWhat they receive
UKA, unicompartmental knee replacementExperimentalProcedure: Participants are operated with a mobile bearing medial unicompartmental knee arthroplasty (Oxford). They are followed with CT, functional tests and PROM, compared with those operated with TKA.
Receives: Procedure: Unicompartmental knee replacement
TKA, total knee replacementExperimentalProcedure: Participants are operated with a cruciate retaining conventional tricompartmental prosthesis (PFC). They are followed with CT, functional tests and PROM, compared with those operated with UKA.
Receives: Procedure: Total knee replacement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle mass

    Thigh muscle cross sectional area and radiological attenuation measured by CT

    Measured: 2 years

Secondary outcomes (3)
  1. Muscle function

    Functional test of quadriceps strength, a stair negotiation test where the patient is asked to perform as many repetitions as possible in 30 seconds.

    Measured: 2 years

  2. Health related outcome measurement, questionnaire

    EQ5D, a qualitative measurement of patient perceived quality of life

    Measured: 2 years

  3. Patient reported outcome measurement, knee function questionnaire (PROM).

    Knee osteoarthritis outcome score (KOOS).

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2015 (estimated)
  2. Study startSep 2015
  3. Primary completionSep 2022 (estimated)
  4. Study completionSep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02563756
Sponsor's protocol ID
UNITKAstudien2015
Acronym
UKA or TKA?
Status last verified
Oct 2020
First submitted
18 Sep 2015
Last updated
26 Oct 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Unicompartmental knee replacement and Total knee replacement in people with Knee Osteoarthritis, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Margareta Hedström, MD, PhD (+4670735959, margareta.hedstrom@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle mass (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
UKA or TKA? Clinical Trial NCT02563756 | AzTrials